Showing results (451-460 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|November 20, 2012
The history of leukemia therapy--a personal journeyEmil J Freireich
Clinical Lymphoma, Myeloma & Leukemia|January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysisDaniel J DeAngelo, Lei Chen, Annie Guerin, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 26, 2023
Clinical Outcomes in Patients With COVID-19 and Hematologic DiseaseOlga A Aleshina, Kristina Zakurdaeva, Anastasia N Vasileva, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndromeYishai Ofran, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphomaRyan D Cassaday, Andre Goy, Suresh Advani, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2015
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation studyJohn F DiPersio, Harry P Erba, Richard A Larson, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 30, 2020
Monitoring Plasma Cell Dyscrasias With Cell-free DNA AnalysisIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2020
The Use of Post-transplantation Cyclophosphamide in Peripheral Blood HLA-matched Stem Cell Transplantation as Graft-versus-host Disease Prophylaxis in Patients With Malignant or Non-malignant Hematologic Disorders: A Single-center Experience of 52 PatientsHossam Kamel Mahmoud, Gamal Mohamed Fathy, Alaa Elhaddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 21, 2015
IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish CohortOmur Gokmen Sevindik, Sinan Mersin, Abdullah Katgi, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
Pageof 251